387 related articles for article (PubMed ID: 23810804)
1. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.
Zhao H; Chang R; Che H; Wang J; Yang L; Fang W; Xia Y; Li N; Ma Q; Wang X
Neurosci Lett; 2013 Sep; 551():12-6. PubMed ID: 23810804
[TBL] [Abstract][Full Text] [Related]
2. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice.
Gao L; Tian S; Gao H; Xu Y
J Mol Neurosci; 2013 Sep; 51(1):138-47. PubMed ID: 23345083
[TBL] [Abstract][Full Text] [Related]
4. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
7. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing mice.
Laporte V; Ait-Ghezala G; Volmar CH; Ganey C; Ganey N; Wood M; Mullan M
Brain Res; 2008 Sep; 1231():132-42. PubMed ID: 18606155
[TBL] [Abstract][Full Text] [Related]
9. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
Zhang ZX; Zhao RP; Wang DS; Li YB
Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
[TBL] [Abstract][Full Text] [Related]
10. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
11. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.
Annamalai B; Won JS; Choi S; Singh I; Singh AK
Biochem Biophys Res Commun; 2015 Feb; 458(1):214-9. PubMed ID: 25640839
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology.
Higuchi M; Iwata N; Matsuba Y; Takano J; Suemoto T; Maeda J; Ji B; Ono M; Staufenbiel M; Suhara T; Saido TC
FASEB J; 2012 Mar; 26(3):1204-17. PubMed ID: 22173972
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
Qin X; Wang Y; Paudel HK
Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
[TBL] [Abstract][Full Text] [Related]
14. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
Shukla V; Skuntz S; Pant HC
Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
[TBL] [Abstract][Full Text] [Related]
15. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
[TBL] [Abstract][Full Text] [Related]
18. Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain.
Guo C; Wang P; Zhong ML; Wang T; Huang XS; Li JY; Wang ZY
Neurochem Int; 2013 Jan; 62(2):165-72. PubMed ID: 23262393
[TBL] [Abstract][Full Text] [Related]
19. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
